Interestingly, hypoferremia in acute COVID‐19 was accompanied by only mildly elevated blood hepcidin levels [37, 39], which may explain the consistently elevated FPN1 levels in the subsets of inflammatory COVID‐19 patients assigned to the participant cluster #2. The gene discussed is HAMP; the disease is COVID-19.